single domain anti-tau antibodies (New York University)

N/A

Report date: 2025/03/20 09:56:48

Base Information

Drug Namesingle domain anti-tau antibodies (New York University)
Drug Alias NamemAbs (New York University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSynuclein alpha modulatorsMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tauSynuclein alpha
Therapy Area/IndicationsAlzheimer DiseaseNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesNew York University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A